These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 280246)
41. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart. García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377 [TBL] [Abstract][Full Text] [Related]
42. Serotonin uptake and serotonin uptake inhibition. Fuller RW; Wong DT Ann N Y Acad Sci; 1990; 600():68-78; discussion 79-80. PubMed ID: 2252338 [TBL] [Abstract][Full Text] [Related]
44. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
45. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats. Sloviter RS; Drust EG; Damiano BP; Connor JD J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720 [No Abstract] [Full Text] [Related]
46. Brain 5-hydroxytryptamine and cyclic AMP in morphine tolerance and dependence. Way EL; Ho IK; Loh HH Adv Biochem Psychopharmacol; 1974; 10():219-31. PubMed ID: 4152551 [No Abstract] [Full Text] [Related]
47. Possible role of brain serotonin and dopamine in controlling male sexual behavior. Gessa GL; Tagliamonte A Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859 [No Abstract] [Full Text] [Related]
49. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers. Waldmeier PC; Baumann PA; Maítre L J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325 [No Abstract] [Full Text] [Related]
50. Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity. Li JX; Rice KC; France CP Behav Pharmacol; 2007 Jul; 18(4):283-8. PubMed ID: 17551320 [TBL] [Abstract][Full Text] [Related]
51. Neuronal transport of 5-hydroxytryptamine. Ross SB Pharmacology; 1980; 21(2):123-31. PubMed ID: 6994132 [No Abstract] [Full Text] [Related]
52. Structure-activity relationships of serotonin neurotoxins: effects on serotonin uptake. Horn AS Ann N Y Acad Sci; 1978 Jun; 305():128-33. PubMed ID: 280246 [No Abstract] [Full Text] [Related]
53. Correlation of inhibitory activity of tryptamine derivatives on serotonin uptake in thrombocyte with van der Waals volume. Gupta SP; Singh P; Bindal MC Arzneimittelforschung; 1981; 31(12):2053-5. PubMed ID: 7199296 [TBL] [Abstract][Full Text] [Related]
54. Quantitation of the uptake of indoleamines and dopamine in the rabbit retina. Ehinger B; Florén I Exp Eye Res; 1978 Jan; 26(1):1-11. PubMed ID: 624320 [No Abstract] [Full Text] [Related]
55. Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues. Horn AS J Neurochem; 1973 Oct; 21(4):883-8. PubMed ID: 4754864 [No Abstract] [Full Text] [Related]
56. The structure-activity relationship of inhibitors of serotonin uptake and receptor binding. Hansch C; Caldwell J J Comput Aided Mol Des; 1991 Oct; 5(5):441-53. PubMed ID: 1770380 [TBL] [Abstract][Full Text] [Related]